Investors

Mole Genetics is a privately held Norwegian biotechnology company founded June 2005. Mole Genetics has benefited by selecting private investors who bring valuable business expertise to the company, in addition to their financial backing.

Mole Genetics' shareholders are:

Skagenkaien Eiendom AS (21,90%)
Skagenkaien Eiendom AS is a privately owned investment company established in 1985. The company invests in commercial properties, shipping and the stock market (both listed and venture capital companies).

Såkorn invest (18,13%)
Såkorn inVest (http://www.sakorn.no/) is an early stage, privately held venture fund. The company was established in 1999, and invests in ventures during the seed and start-up phases. The main criteria for investments are an outstanding management team in addition to a high potential for growth.

Spencer Energy AS (11,6%)
Spencer Energy is a company owned by Mr. Arne Blystad. Spencer Energy invests in companies within offshore, renewable energy, marine technology and biotech related business.

Tvenge Holding AS (9,86%)
Tvenge Holding AS is a company owned by Mr. Torstein Tvenge. Tvenge has been a strategic and financial investor in various industries for several decades. Since the early 1980's he has also been a real estate entrepreneur building within both commercial and residential segments.

Tom Hagen Funds AS (7,79%)
is a privately owned investment company which invests in the stock market and selected privately held companies.

Initia AS (5,94%)

Trinity Capital AS (4,65%)
is a privately owned investment company for the founders of NorgesInvestor AS. The company invests in projects outside the investment focus of NorgesInvestor AS.

Frank Larsen (4,24%)

Arne Deggerdal (4,13%)

Tone Yrvum (4,2%)

Ballista AS (2,85%)

Freyer Holding AS (1,55%)

RO Invest AS (1,55%)

Bjøberg 2 AS (1,16%)

Einar Unhjem Johansen (0,2%)

LM&C AS (0,17%)

Andrew Campbell (0,08%)

 
For inquiries concerning investment opportunities or corporate sponsorship, please contact Frank Larsen, CEO/Managing Director at frank.larsen@molegenetics.com (phone: +47 67 10 18 20)